{
    "Trade/Device Name(s)": [
        "ACE Axcel Clinical Chemistry System",
        "ACE Hemoglobin A1c (HbA1c) Reagent",
        "ACE CEDIA T Uptake Reagent",
        "ACE T4 Reagent",
        "ACE Ferritin Reagent"
    ],
    "Submitter Information": "Alfa Wassermann Diagnostic Technologies, LLC",
    "510(k) Number": "K113437",
    "Predicate Device Reference 510(k) Number(s)": [
        "K931786",
        "K063306",
        "K981375",
        "K981377",
        "K050944"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "KHQ",
        "KLI",
        "DBF"
    ],
    "Summary Letter Date": "July 30, 2012",
    "Summary Letter Received Date": "July 31, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR864.7470",
        "21CFR862.1715",
        "21CFR862.1700",
        "21CFR866.5340",
        "21CFR862.2610"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay",
        "Triiodothyronine uptake radioassay",
        "Total thyroxine enzyme immunoassay",
        "Ferritin antigen/antiserum/control",
        "Analyzer, chemistry (photometric, discrete)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c",
        "Total hemoglobin",
        "Thyroxine (T4)",
        "Triiodothyronine uptake",
        "Ferritin",
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "EDTA whole blood",
        "Serum",
        "Blood",
        "Other fluids"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Primary draw tube",
        "Sample cup"
    ],
    "Instrument(s)/Platform(s)": [
        "ACE Axcel Clinical Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "Latex agglutination inhibition assay",
        "Homogeneous enzyme immunoassay",
        "Photometric measurement",
        "Turbidimetric measurement",
        "Electrolyte measurement",
        "Enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Quantitative determination",
        "Agglutination",
        "Colorimetric measurement",
        "Spectrophotometry",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Reagent",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Alfa Wassermann ACE Axcel Clinical Chemistry System and reagents for the quantitative analysis of hemoglobin A1c, triiodothyronine uptake, thyroxine, and ferritin in blood/serum",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of hemoglobin A1c and total hemoglobin in EDTA whole blood, triiodothyronine uptake, thyroxine, and ferritin in serum, to aid diagnosis and monitoring of diabetes mellitus, thyroid disorders, and diseases affecting iron metabolism using the ACE Axcel Clinical Chemistry System",
    "fda_folder": "Hematology"
}